• Aucun résultat trouvé

Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD Short title: Bile acids in meta-inflammatory disorders

N/A
N/A
Protected

Academic year: 2021

Partager "Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD Short title: Bile acids in meta-inflammatory disorders"

Copied!
49
0
0

Texte intégral

Loading

Références

Documents relatifs

As HOs need financial resources provided by donors to run their operations, we focus on understanding what strategies HOs follow to reduce dependence on donors and

La formation comprend une partie théorique sur le fonctionnement de l’outil Logiciel Premiers signes et une partie pratique ou les enseignantes réalisent le dépistage de

(A-E) Expression levels of the FOXA2 target gene Igfbp1, of the FXR target gene Slc51b/Ostb and of the gluconeogenic genes Fbp1, Pck1 and G6pc in response to GW4064, insulin,

Finally, each personalized community model was constrained with an “Average European” diet supplemented with conjugated primary bile acids and its individual-specific, primary bile

low levels of long-chain fatty acids (LCFA) but leading to high levels of volatile fatty acid (VFA) pro- duction by the rumen microflora. Such differences in dietary

Abstract: The plasma concentration of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, is the resultant of many processes at cellular and

Upon ligand activation, the nuclear corepressors are released and the coactivator complexes are then recruited and bound to PPARα/RXRα heterodimers, hence inducing expression

This has been clearly observed experimentally since the resistance of the chain of beads depends a lot on the beads chosen or even on the electrical contacts between the beads, but